Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Tirzepatide injections Tirzepatide, a dual agonist of gastric inhibitory peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, helps reduce appetite and enhance insulin sensitivity by imitating these effects of these hormones
Krenkel O, Mossanen JC, Tacke F
Originally created for type 2 diabetes treatment, researchers discovered an unexpected benefit: patients taking the drug experienced decreased appetite and subsequent weight loss
Community-shared single-use codes available only on Tenereteam
Phytochemicals can improve diabetic wound healing by regulating oxidative stress and inflammation, with agents like resveratrol also supporting glycemic control and reducing complications
Yet postmarketing reviews tell a different story, with up to 15% of users reporting body aches that were not captured in controlled trials
